GREG MCCARTNEY: Open Payments
NPI 1710945498 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,025 in 119 payments from 17 companies in 2025. Trend: 2023 $1,402 · 2024 $1,334 · 2025 $2,025
Food & beverage: $2,025
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $494 |
| AstraZeneca Pharmaceuticals LP | 14 | $324 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $214 |
| ABBVIE INC. | 13 | $185 |
| Amgen Inc. | 12 | $153 |
| Novartis Pharmaceuticals Corporation | 8 | $151 |
| Sumitomo Pharma America, Inc. | 5 | $97 |
| Corcept Therapeutics | 3 | $73 |
| Astellas Pharma US Inc | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 5 | $52 |
Products named: AIRSUPRA, LEQVIO, Ozempic, XIFAXAN, Wegovy, FARXIGA, Rybelsus, UBRELVY.
Industry payments across WV — which companies pay providers there.
